19-Sep-2019 - Rijksuniversiteit Groningen

Scientists construct energy production unit for a synthetic cell

Scientists at the University of Groningen have constructed synthetic vesicles in which ATP, the main energy carrier in living cells, is produced. The vesicles use the ATP to maintain their volume and their ionic strength homeostasis. This metabolic network will eventually be used in the creation of synthetic cells - but it can already be used to study ATP-dependent processes. The researchers described the synthetic system in an article that was published in Nature Communications on 18 September.

'Our aim is the bottom-up construction of a synthetic cell that can sustain itself and that can grow and divide,' explains University of Groningen Professor of Biochemistry Bert Poolman. He is part of a Dutch consortium that obtained a Gravitation grant in 2017 from the Netherlands Organisation for Scientific Research to realize this ambition. Different groups of scientists are producing different modules for the cell and Poolman's group was tasked with energy production.


All living cells produce ATP as an energy carrier but achieving sustainable production of ATP in a test tube is not a small task. 'In known synthetic systems, all components for the reaction were included inside a vesicle. However, after about half an hour, the reaction reached equilibrium and ATP production declined,' Poolman explains. 'We wanted our system to stay away from equilibrium, just like in living systems.'

It took three Ph.D. students in his group nearly four years to construct such a system. A lipid vesicle was fitted out with a transport protein that could import the substrate arginine and export the product ornithine. Inside the vesicle, enzymes were present that broke down the arginine into ornithine. The free energy that this reaction provided was used to link phosphate to ADP, forming ATP. Ammonium and carbon dioxide were produced as waste products that diffused through the membrane. 'The export of ornithine produced inside the vesicle drives the import of arginine, which keeps the system running for as long as the vesicles are provided with arginine,' explains Poolman.

Transport protein

To create an out-of-equilibrium system, the ATP is used to maintain ionic strength inside the vesicle. A biological sensor measures ionic strength and if this becomes too high, it activates a transport protein that imports a substance called glycine betaine. This increases the cell volume and consequently reduces the ionic strength. 'The transport protein is powered by ATP, so we have both production and use of ATP inside the vesicle.'

The system was left to run for 16 hours in the longest experiment that the scientists have performed. 'This is quite long - some bacteria can divide after just 20 minutes,' says Poolman. 'The current system should suffice for a synthetic cell that divides once every few hours.' Eventually, different modules like this one will be combined to create a synthetic cell that will function autonomously by synthesizing its own proteins from a synthetic genome.

Artificial chromosome

The current system is based on biochemical components. However, Poolman's colleagues at Wageningen University & Research are busy collecting the genes needed for the production of enzymes used by the system and incorporating them into an artificial chromosome. Others are working on lipid and protein synthesis, for example, or cell division. The final synthetic cell should contain DNA for all these modules and operate them autonomously like a living cell, but in this case, engineered from the bottom-up and including new properties. However, this is many years away. 'In the meantime, we are already using our ATP-producing system to study ATP-dependent processes and advance the field of membrane transport,' says Poolman.

  • Tjeerd Pols, Hendrik R. Sikkema, Bauke F. Gaastra, Jacopo Frallicciardi, Wojciech M. Smigiel, Shubham Singh and Bert Poolman; "A synthetic metabolic network for physicochemical homeostasis"; Nature Communications; 18 September 2019
Facts, background information, dossiers
More about Uni Groningen
  • News

    Simulations show how to make gene therapy more effective

    Diseases with a genetic cause could, in theory, be treated by supplying a correct version of the faulty gene. However, in practice, delivering new genetic material to human cells is difficult. A promising method for the delivery of such genes involves the use of DNA/lipid complexes (lipople ... more

    Small-volume, high-throughput organic synthesis

    University of Groningen Professor of Drug Design, Alexander Dömling, has devised a method to rapidly synthesize thousands of new molecules and evaluate their properties as potential drugs. In a paper published by Science Advances on 5 July, he shows that this method works well when applied ... more

    Optimized Binding Cavity

    The impressively high conversion rates of natural enzymes partly result from increasing the catalytic activity of a selected few amino acid side chains through precise positioning within the protein binding cavity. Scientists have now demonstrated that such fine-tuning is also possible for ... more